Aura Biosciences (AURA) Retained Earnings (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Retained Earnings data on file, last reported at -$514.1 million in Q1 2026.

• Quarterly Retained Earnings fell 27.98% year-over-year to -$514.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$514.1 million (down 27.98% YoY) and the FY2025 annual result came in at -$480.4 million, down 28.38% from the prior year.
• Retained Earnings slipped to -$514.1 million in Q1 2026, from -$480.4 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $611.5 million in Q3 2025 to a low of -$514.1 million in Q1 2026.
• A 5-year average of $14.3 million and a median of -$147000.0 in 2022 frame the typical range for Retained Earnings.
• The widest YoY moves for Retained Earnings: up 323010.16% in 2023, down 180292.52% in 2023.
• Tracing AURA's Retained Earnings over 5 years: stood at $406.6 million in 2022, then grew by 26.09% to $512.6 million in 2023, then sank by 173.0% to -$374.2 million in 2024, then fell by 28.38% to -$480.4 million in 2025, then slipped by 7.01% to -$514.1 million in 2026.
• The last three Retained Earnings figures came in at -$514.1 million (Q1 2026), -$480.4 million (Q4 2025), and $611.5 million (Q3 2025), per Business Quant data.